Figure 8

Visualization of active compounds‒potential targets‒signaling pathways: yellow nodes represent the active compound, pink nodes represent the signaling pathway, and green nodes represent the potential target. hsa05215-Prostate cancer; hsa05200-Pathways in cancer; hsa05161-Hepatitis B;hsa04066-HIF-1 signaling pathway; hsa05221-Acute myeloid leukemia; hsa05212-Pancreatic cancer; hsa04914-Progesterone-mediated oocyte maturation; hsa05220-Chronic myeloid leukemia; hsa05205-Proteoglycans in cancer; hsa05169-Epstein-Barr virus infection; hsa04110-Cell cycle; hsa04068-FOXO signaling pathway; hsa04062-Chemokine signaling pathway; hsa04071-Sphingolipid signaling pathway; hsa05230-Central carbon metabolism in cancer; hsa05142-Chagas disease (American trypanosomiasis); hsa04151-PI3K-Akt signaling pathway; hsa05222-Small cell lung cancer; hsa04012-ErbB signaling pathway; hsa05203-Viral carcinogenesis; hsa04380-Osteoclast differentiation; hsa04662-B cell receptor signaling pathway; hsa05213-Endometrial cancer; hsa05160-Hepatitis C; hsa04917-Prolactin signaling pathway; hsa04919-Thyroid hormone signaling pathway; hsa04722-Neurotrophin signaling pathway; hsa04024-cAMP signaling pathway; hsa05206-MicroRNAs in cancer; hsa05210Colorectal cancer.